Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication

被引:10
作者
Hennessey, KA [1 ]
Marx, A
Hafiz, R
Ashgar, H
Hadler, SC
Jafari, H
Sutter, RW
机构
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Informat Serv E34, Eradicat Div,Vaccine Preventable Div, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Epidemiol Program Off, Epidem Intelligence Serv, Atlanta, GA 30333 USA
[3] WHO, Islamabad, Pakistan
[4] Natl Inst Hlth, Islamabad, Pakistan
[5] WHO, Eastern Mediterranean Reg, Alexandria, Egypt
关键词
D O I
10.1086/315675
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite substantial efforts to eradicate poliomyelitis by administering oral poliovirus vaccine through routine immunization and annual national immunization days (NIDs), Pakistan reported 22% (1147) of the worldwide cases in 1997, Reasons for continued high poliomyelitis incidence include failure to vaccinate, vaccine failure, or inadequate immunization strategies, A case-control study was conducted to measure vaccination status and reasons for undervaccination among 66 poliomyelitis cases and 130 age- and neighborhood-matched controls. Cases were undervaccinated through routine immunization (matched odds ratio [MOR], 0.3; 95% confidence interval [CI], 0.1-0.5); however, NID immunization was similar for cases and controls (MOR, 0.6; 95% CI, 0.3-1.2), Reasons for undervaccination included not being informed, considering vaccination unimportant, and long distances to vaccination sites. Failure to vaccinate through routine immunization was a major risk factor for poliomyelitis in Pakistan, Successful NIDs alone will not interrupt poliovirus circulation in Pakistan, and children remain at risk unless routine immunization is strengthened or additional supplementary immunization is provided.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 10 条
[1]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P793
[2]  
ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055
[3]  
PATRIARCA PA, 1991, REV INFECT DIS, V13, P926
[4]   Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan [J].
Reichler, MR ;
Kharabsheh, S ;
Rhodes, P ;
Otoum, H ;
Bloch, S ;
Majid, MA ;
Pallansch, MA ;
Patriarca, PA ;
Cochi, SL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 :S198-S204
[5]   Evaluation of oral poliovirus vaccine delivery during the 1994 national immunization days in Pakistan [J].
Reichler, MR ;
Aslanian, R ;
Lodhi, ZH ;
Latif, I ;
Khan, MA ;
Chaudhry, R ;
Idris, AA ;
Barzgar, MA .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 :S205-S209
[6]  
*SAS I, 1997, SAS STAT SOFTW CHANG
[7]   Progress toward poliomyelitis eradication in the Eastern Mediterranean Region of the World Health Organization [J].
Wahdan, MH ;
Aslanian, R ;
Reichler, MR ;
Gaafar, MT .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 :S50-S55
[8]  
*WHO, 1991, MAN VIR INV POL GEN
[9]  
*WHO, 1988, WKLY EPIDEMIOL REC, V63, P161
[10]  
*WHO E MED UNICEF, 1998, POLIOFAX, V64, P2